FierceBiotech 2025-12-04 FDA floats user fee cuts for early-stage US trials, additional fees for overseas development
Endpoints News 2025-12-03 FDA to name Tracy Beth Høeg, who helped lead Covid-shot investigation, to head CDER
Thermo Fisher 2025-12-03 Thermo Fisher Scientific Insider Sold Shares Worth $8,154,131, According to a Recent SEC Filing - MarketScreener
FierceBiotech 2025-12-03 Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy
Endpoints News 2025-12-03 FDA seeks to raise user fees for companies running Phase 1 trials outside the US
Lonza News 2025-12-03 Biologics CDMO Market Trends and Investment Forecast to 2033: Features Analysis of Lonza Group, Cata - PharmiWeb.com
Endpoints News 2025-12-03 FDA says it won't release details of claimed Covid vaccine deaths in 'near term'
BioPharma Dive 2025-12-03 After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis
Endpoints News 2025-12-03 With Phase 3 Duchenne success, Capricor plots path forward after FDA rejection